Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics

RIGL POWR Grades

• Value is the dimension where RIGL ranks best; there it ranks ahead of 87.3% of US stocks.
• The strongest trend for RIGL is in Value, which has been heading up over the past 179 days.
• RIGL's current lowest rank is in the Stability metric (where it is better than 6.5% of US stocks).

RIGL Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for RIGL is -4.5 -- better than just 3.08% of US stocks.
• RIGL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 3.1% of US stocks.
• As for revenue growth, note that RIGL's revenue has grown 43.09% over the past 12 months; that beats the revenue growth of 87.29% of US companies in our set.
• Stocks that are quantitatively similar to RIGL, based on their financial statements, market capitalization, and price volatility, are CTSO, ADTX, RNLX, NURO, and NTGR.
• RIGL's SEC filings can be seen here. And to visit RIGEL PHARMACEUTICALS INC's official web site, go to www.rigel.com.

RIGL Valuation Summary

• RIGL's price/sales ratio is 1.5; this is 21.05% lower than that of the median Healthcare stock.
• Over the past 243 months, RIGL's price/sales ratio has gone down 13.9.

Below are key valuation metrics over time for RIGL.

RIGL Growth Metrics

Its year over year cash and equivalents growth rate is now at 23.11%.
• Its 2 year cash and equivalents growth rate is now at -45.43%.
• Its year over year revenue growth rate is now at -36.54%.

RIGL's revenue has moved up $30,085,000 over the prior 33 months.

The table below shows RIGL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	89.373	-70.935	-82.615
2022-06-30	88.506	-67.931	-84.53
2022-03-31	84.953	0.196	-84.859
2021-12-31	149.236	5.878	-17.914
2021-09-30	147.277	9.392	-14.51
2021-06-30	144.123	0.207	-7.732

RIGL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• RIGL has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• RIGL's asset turnover comes in at 0.825 -- ranking 30th of 682 Pharmaceutical Products stocks.
• GERN, NEOG, and VNDA are the stocks whose asset turnover ratios are most correlated with RIGL.

The table below shows RIGL's key quality metrics over time.